Is Mineralys Therapeutics, Inc. (MLYS) a Buy, Sell, or Hold?
NASDAQ : MLYS
Mineralys Therapeutics, Inc. — Competitors
$26.95 USD
-$0.26 (-0.96%)
- Volume
- 546.65K
- Average Volume
- 1.5M
- Market Capitalization
- $2.38B
- P/E Ratio
- -13.15
- Dividend Yield
- 0.00%
- Price Target
- $43.00
- Year High
- $47.65
- Year Low
- $12.59
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $44.33
MLYS vs. The Competition
| Properties | MLYS | ADPT | AGIO | APLS |
|---|---|---|---|---|
| Market Cap | $2.38B | $3.6B | $2.14B | $5.25B |
| Shares Outstanding | $88.16M | $160.04M | $59.47M | $128.02M |
| P/E Ratio | -13.15 | -68.78 | -4.96 | 38.71 |
| EPS | -1.83 | -0.32 | -7.19 | 1.06 |
| Day Low | 26.49 | 21.93 | 35.24 | 41.03 |
| Day High | 27.675 | 22.9899 | 37.56 | 41.05 |
| Year Low | 12.59 | 9.955 | 22.24 | 16.61 |
| Year High | 47.65 | 23.15 | 46 | 41.14 |
| Average Price 50 | 27.0419 | 18.4054 | 33.7732 | 33.6049 |
| Average Price 200 | 31.81503 | 16.43515 | 31.78985 | 26.15373 |
| Volume | 546.65K | 1.68M | 802.34K | 28.64M |
| Average Volume | - | - | - | - |